Key Organics has supported many drug discovery programs, from hit validation to preclinical studies. We have particular expertise in the scale-up of synthetic routes to prepare multigram quantities of a lead compound for further studies. As many of our customers work to tight deadlines, we seek to optimise read morethe efficiency of a scale-up route by reducing the number of steps and finding alternatives to chromatographic purification. Our chemists work closely with our in-house analytical team to ensure that final compounds meet or exceed the purity specification required by the customer, we can also provide SDS, BSE/TSE, GMO statements as needed by the client. We have in house experience of synthesizing various salts of the desired compound to aid salt screening and polymorphism studies.

Kingchem Life Science is a leading chemical manufacturing company that specializes in the production of APIs, both GMP and non-GMP intermediates, as well as custom small molecules. Kingchem serves the pharmaceutical, agrochemical, electronic, and fine and specialty chemical industries. Their Wisconsin based cGMP manufacturing facility offers APIs and read moreGMP intermediates out of the USA, while their facility in Fuxin, China offers the highest level of non-GMP service to customers focused on RSMs and other complex building blocks.  Kingchem’s dedicated R&D, Analytical, and Quality Assurance teams help customers navigate the complex landscape of drug development for both clinical and commercial supply.  From the kilogram to the hundreds of metric tons range, the company is well positioned to tailor a solution to meet your needs for custom manufacturing, process development and contract research.  Let Kingchem go Beyond The Chemistry™ and provide your supply-chain security.

Kyongbo Pharmaceutical Co., Ltd. was founded in 1987. Since then, with our experience in manufacturing various APIs, we have become the No.1 API manufacturer in Korea.

Now, there are seven API production workshops at Asan in Korea. With them, we have accumulated expertise and experience in API read moreproduction to implement projects of new drug joint-development and CMO·CDMO business implementing non-clinical and clinical research of phase I, II, III to commercial production. 

Kyongbo has specialized plants and quality systems to manufacture APIs qualified to meet cGMP standards. Also, it has gone through regular audits and approval from USFDA, EDQM, PMDA, and KFDA.

Moreover, with personnel with accumulated experience and great expertise, the CMO Business Unit (CBU) of Kyongbo has been focusing on and implementing a variety of CMO · CDMO projects, expanding our business globally. This team enables communication and quick response with our clients effectively.

It possesses a variety of manufacturing facilities and analytical equipment (NMR, PXRD, HPLC, UPLC, FT-IR, UV-Vis, LC (GC)-ass, ICP, DSC, TGA, PSD, SEM, Electron Microscope, etc.) to develop and manufacture a high-quality large and small amount of APIs.

Kyongbo can service;

• Process Development & Optimization
• Test Method Development & Validation
• Technical Transfer Process for Safety and Control Quality with PAT Tools
• Lab, Pilot (<50L) and Full-scale (300L~12,000L) APIs Manufacturing
• High-potency (Cytotoxic & non-Cytotoxic APIs) Plant